Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2013 7
2014 9
2015 4
2016 6
2017 5
2018 9
2019 5
2020 10
2021 7
2022 11
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial.
Delgado-Lista J, Alcala-Diaz JF, Torres-Peña JD, Quintana-Navarro GM, Fuentes F, Garcia-Rios A, Ortiz-Morales AM, Gonzalez-Requero AI, Perez-Caballero AI, Yubero-Serrano EM, Rangel-Zuñiga OA, Camargo A, Rodriguez-Cantalejo F, Lopez-Segura F, Badimon L, Ordovas JM, Perez-Jimenez F, Perez-Martinez P, Lopez-Miranda J; CORDIOPREV Investigators. Delgado-Lista J, et al. Among authors: rangel zuniga oa. Lancet. 2022 May 14;399(10338):1876-1885. doi: 10.1016/S0140-6736(22)00122-2. Epub 2022 May 4. Lancet. 2022. PMID: 35525255 Clinical Trial.
Mediterranean diet and endothelial function in patients with coronary heart disease: An analysis of the CORDIOPREV randomized controlled trial.
Yubero-Serrano EM, Fernandez-Gandara C, Garcia-Rios A, Rangel-Zuñiga OA, Gutierrez-Mariscal FM, Torres-Peña JD, Marin C, Lopez-Moreno J, Castaño JP, Delgado-Lista J, Ordovas JM, Perez-Martinez P, Lopez-Miranda J. Yubero-Serrano EM, et al. Among authors: rangel zuniga oa. PLoS Med. 2020 Sep 9;17(9):e1003282. doi: 10.1371/journal.pmed.1003282. eCollection 2020 Sep. PLoS Med. 2020. PMID: 32903262 Free PMC article. Clinical Trial.
Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial.
Roncero-Ramos I, Gutierrez-Mariscal FM, Gomez-Delgado F, Villasanta-Gonzalez A, Torres-Peña JD, Cruz-Ares S, Rangel-Zuñiga OA, Luque RM, Ordovas JM, Delgado-Lista J, Perez-Martinez P, Camargo A, Alcalá-Diaz JF, Lopez-Miranda J. Roncero-Ramos I, et al. Among authors: rangel zuniga oa. Transl Res. 2021 Dec;238:12-24. doi: 10.1016/j.trsl.2021.07.001. Epub 2021 Jul 21. Transl Res. 2021. PMID: 34298148 Free article. Clinical Trial.
Association between telomere length and intima-media thickness of both common carotid arteries in patients with coronary heart disease: From the CORDIOPREV randomized controlled trial.
Ojeda-Rodriguez A, Alcala-Diaz JF, Rangel-Zuñiga OA, Arenas-de Larriva AP, Gutierrez-Mariscal FM, Gómez-Luna P, Torres-Peña JD, Garcia-Rios A, Romero-Cabrera JL, Malagon MM, Perez-Martinez P, Ordovas JM, Delgado-Lista J, Yubero-Serrano EM, Lopez-Miranda J. Ojeda-Rodriguez A, et al. Atherosclerosis. 2023 Sep;380:117193. doi: 10.1016/j.atherosclerosis.2023.117193. Epub 2023 Jul 28. Atherosclerosis. 2023. PMID: 37549582 Clinical Trial.
Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study.
Mora-Ortiz M, Alcala-Diaz JF, Rangel-Zuñiga OA, Arenas-de Larriva AP, Abollo-Jimenez F, Luque-Cordoba D, Priego-Capote F, Malagon MM, Delgado-Lista J, Ordovas JM, Perez-Martinez P, Camargo A, Lopez-Miranda J. Mora-Ortiz M, et al. BMC Med. 2022 Oct 27;20(1):373. doi: 10.1186/s12916-022-02566-z. BMC Med. 2022. PMID: 36289459 Free PMC article. Clinical Trial.
CORDIOPREV and the traditional Mediterranean diet-Authors' response.
Cano-Ibáñez N, Quintana-Navarro GM, Alcala-Diaz JF, Rangel-Zuñiga OA, Camargo A, Yubero-Serrano EM, Perez-Corral I, Larriva APA, Garcia-Rios A, Perez-Martinez P, Delgado-Lista J, Lopez-Miranda J. Cano-Ibáñez N, et al. Among authors: rangel zuniga oa. Eur J Nutr. 2022 Dec;61(8):4229-4230. doi: 10.1007/s00394-022-03008-5. Epub 2022 Oct 3. Eur J Nutr. 2022. PMID: 36190575 No abstract available.
Localization, traffic and function of Rab34 in adipocyte lipid and endocrine functions.
López-Alcalá J, Gordon A, Trávez A, Tercero-Alcázar C, Correa-Sáez A, González-Rellán MJ, Rangel-Zúñiga OA, Rodríguez A, Membrives A, Frühbeck G, Nogueiras R, Calzado MA, Guzmán-Ruiz R, Malagón MM. López-Alcalá J, et al. Among authors: rangel zuniga oa. J Biomed Sci. 2024 Jan 5;31(1):2. doi: 10.1186/s12929-023-00990-8. J Biomed Sci. 2024. PMID: 38183057 Free PMC article.
Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial.
Ojeda-Rodriguez A, Rangel-Zuñiga OA, Arenas-de Larriva AP, Gutierrez-Mariscal FM, Torres-Peña JD, Romero-Cabrera JL, Podadera-Herreros A, García-Fernandez H, Porras-Pérez E, Luque RM, Kales SN, Perez-Martinez P, Delgado-Lista J, Yubero-Serrano EM, Lopez-Miranda J. Ojeda-Rodriguez A, et al. Among authors: rangel zuniga oa. Cardiovasc Diabetol. 2024 Mar 16;23(1):98. doi: 10.1186/s12933-024-02175-5. Cardiovasc Diabetol. 2024. PMID: 38493287 Free PMC article. Clinical Trial.
Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study.
Roncero-Ramos I, Alcala-Diaz JF, Rangel-Zuñiga OA, Gomez-Delgado F, Jimenez-Lucena R, García-Rios A, Vals-Delgado C, Romero-Baldonado C, Luque RM, Ordovas JM, Perez-Martinez P, Camargo A, Lopez-Miranda J. Roncero-Ramos I, et al. Among authors: rangel zuniga oa. Clin Nutr. 2020 Feb;39(2):492-500. doi: 10.1016/j.clnu.2019.02.027. Epub 2019 Feb 21. Clin Nutr. 2020. PMID: 30852029 Clinical Trial.
66 results